Dermatology
Latest News
Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b study
Similar to the primary outcome of PASI 75, all treatment groups demonstrated a statistically significant dose-response in PASI 90, compared with...
Latest News
JAK inhibitors efficacious for atopic dermatitis in Asian patients, study finds
The Singapore study is one of the few that have examined the safety and efficacy of JAK inhibitors for treatment of AD in a non-White population...
Latest News
Study finds subcutaneous spesolimab reduces flares in patients with GPP
The intravenous formulation of spesolimab was approved for the treatment of GPP flares in adults by the Food and Drug Administration in September...
Latest News
FDA adds safety-related information to its dermal filler webpage
The update relates delayed-onset inflammation that has been reported to occur near filler treatment sites after viral or bacterial illnesses or...
Latest News
Hairy moles may contain the cure for baldness: Study
Researchers analyzed hair follicle stem cells and discovered that a molecule called osteopontin drives accelerated hair growth.
Latest News
For psoriasis, review finds several biosimilars as safe and effective as biologics
“The biosimilars evaluated in this study could be considered alongside originators for biologic-naive patients to improve the accessibility of...
Feature
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...
Latest News
Study points to need to improve identification of culprit in SJS/TEN cases
A single culprit drug was labeled in 17 cases, but physicians communicated certainty in only 7 of those cases.
Latest News
Imaging techniques will revolutionize cancer detection, expert predicts
Jennifer Barton, PhD, and her colleagues are developing an OCT/fluorescence imaging falloposcope that is 0.8 mm in diameter, flexible, and...
Latest News
Study supports new NCCN classification for cutaneous squamous cell carcinoma
The high- and very-high-risk groups in the NCCN guidelines identify SCCs at greatest risk for developing poor outcomes.
Latest News
FDA passes on olorofim despite critical need for antifungals
There are only four antifungal classes currently available, and there are few new candidates in the pipeline.